From early-stage biotechs to venture-backed startups, the path to the clinic is rarely straightforward — and that’s exactly where we come in.
At Axxam, we’re not just offering services. We’re offering:
Flexible, science-first collaboration models
Custom-built assay solutions, not just off-the-shelf options
Expertise in GPCRs, ion channels, phenotypic screening, and iPSC platforms
Data that’s rigorous, reproducible, and ready for decisions
Whether you’re refining your pipeline or laying the groundwork for your first big hit, we can help you move forward with clarity and confidence.


